NASDAQ:KFX

Kofax Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average Volume512,365 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive KFX News and Ratings via Email

Sign-up to receive the latest news and ratings for Kofax and its competitors with MarketBeat's FREE daily newsletter.

About Kofax

Kofax Limited (Kofax) is a provider of smart process applications software and related maintenance and professional services for the critical First Mile of interactions between businesses, government agencies and other organizations (collectively, organizations) and their customers, citizens, vendors, employees and other parties (collectively, constituents). The First Mile represents those initial information-intensive interactions customers have with organizations. The Company's software enables organizations to design, deploy, and operate comprehensive systems that create an essential link between their systems of engagement, which generate real time, information-intensive communications from constituents, and their systems of record, which are typically large scale enterprise applications and repositories used to manage their internal operations. In September 2014, the Company acquired Softpro GmbH.

Public Key Infrastructure Market Worth Observing Growth: Docusign, Comodo, GoDaddy
March 17, 2020 | www.marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: N/A
Sub-Industry: N/A
Sector: N/A
Current Symbol: NASDAQ:KFX
Previous Symbol
CUSIP: N/A
CIK: 1556884
Web: www.kofax.com
Phone: +1-441-2951442
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.91 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Kofax.

4.5 Community Rank

Outperform Votes
Kofax has received 77 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Kofax has received 36 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Kofax has received 68.14% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Kofax and other stocks. Vote “Outperform” if you believe KFX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe KFX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Kofax does not currently pay a dividend.
Dividend Growth
Kofax does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Kofax insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Kofax (NASDAQ:KFX) Frequently Asked Questions

What stocks does MarketBeat like better than Kofax?: Wall Street analysts have given Kofax a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Kofax wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
What other stocks do shareholders of Kofax own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Kofax investors own include Endocyte (ECYT), Alnylam Pharmaceuticals (ALNY), Akorn (AKRX), Achaogen (AKAO), Agile Therapeutics (AGRX), Aeterna Zentaris (AEZS), Advaxis (ADXS), AcelRx Pharmaceuticals (ACRX), Achillion Pharmaceuticals (ACHN) and Aurora Cannabis (ACBFF).
What is Kofax's stock symbol?: Kofax trades on the NASDAQ under the ticker symbol "KFX."
What is Kofax's official website?: The official website for Kofax is www.kofax.com.
Where are Kofax's headquarters?: Kofax is headquartered at 15211 Laguna Canyon Rd, IRVINE, CA 92618-3146, United States.
How can I contact Kofax?: Kofax's mailing address is 15211 Laguna Canyon Rd, IRVINE, CA 92618-3146, United States. The company can be reached via phone at +1-441-2951442.

This page was last updated on 10/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.